1 |
F25, Schizo-affective disorders |
2.4 |
<10−4
|
2 |
F20, Schizophrenia |
2.4 |
<10−4
|
3 |
M19, Osteoarthritis (unspecified) |
2.9 |
<10−4
|
4 |
N04, Nephrotic syndrome |
2.2 |
<10−4
|
5 |
J41, Simple, mucopurulent chronic bronchitis |
2.1 |
<10−3
|
6 |
J42, Chronic bronchitis (unspecified) |
2.0 |
<10−3
|
7 |
M15, Polyosteoarthritis |
2.6 |
<10−3
|
8 |
N03, Chronic nephritic syndrome |
2.3 |
<10−3
|
9 |
F22, Delusional disorders |
2.6 |
<10−3
|
10 |
M18, Osteoarthritis (first carpometacarpal joint) |
2.5 |
<10−3
|
|
pathway-based,
α = P
|
|
|
1 |
F32, Major depressive disorder, single episode |
1.1 |
<10−3
|
2 |
F33, Major depressive disorder, recurrent |
0.81 |
0.002 |
3 |
M85, Disorders of bone density and structure |
1.8 |
0.003 |
4 |
G40, Epilepsy and recurrent seizures |
0.65 |
0.003 |
5 |
E66, Overweight and obesity |
0.83 |
0.006 |
6 |
E85, Amyloidosis |
0.58 |
0.009 |
7 |
G25, Other extrapyramidal and movement disorders |
0.66 |
0.010 |
8 |
H90, Conductive and sensorineural hearing loss |
0.56 |
0.010 |
9 |
M21, Other acquired deformities of limbs |
1.3 |
0.010 |
10 |
C90, Multiple myeloma, plasma cell neoplasms |
0.90 |
0.011 |
|
toxicogenomic,
α = T
|
|
|
1 |
I71, Aortic aneurysm and dissection |
0.75 |
0.002 |
2 |
L21, Seborrheic dermatitis |
0.65 |
0.002 |
3 |
L24, Irritant contact dermatitis |
0.99 |
0.002 |
4 |
K52, Gastroenteritis and colitis |
0.64 |
0.002 |
5 |
N03, Chronic nephritic syndrome |
1.7 |
0.004 |
6 |
L20, Atopic dermatitis |
1.2 |
0.004 |
7 |
L28, Lichen simplex chronicus and prurigo |
0.69 |
0.006 |
8 |
L30, Unspecified dermatitis |
0.58 |
0.006 |
9 |
I89, Noninfective disorders of lymphatic vessels and nodes |
0.84 |
0.008 |
10 |
G91, Hydrocephalus |
0.96 |
0.009 |